In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs

被引:5
作者
Cohen, MA
Huband, MD
机构
关键词
D O I
10.1093/jac/40.2.308
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:308 / 309
页数:2
相关论文
共 6 条
[1]  
*AM TYP CULT COLL, 1996, BACT BACT, P513
[2]  
FELMINGHAM D, 1993, DRUGS S3, V45, P188
[3]  
FELMINGHAM D, 1996, 36 INT C ANT AG CHEM, P101
[4]   Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219) [J].
Kenny, GE ;
Cartwright, FD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :1048-1049
[5]  
MILLER JM, 1991, MANUAL CLIN MICROBIO, P1263
[6]   INVITRO SUSCEPTIBILITIES OF MYCOPLASMA-PNEUMONIAE, MYCOPLASMA-HOMINIS, AND UREAPLASMA-UREALYTICUM TO SPARFLOXACIN AND PD-127391 [J].
WAITES, KB ;
DUFFY, LB ;
SCHMID, T ;
CRABB, D ;
PATE, MS ;
CASSELL, GH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1181-1185